Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure patients diagnosed with pancreatic cancer access (a) relevant research and (b) clinical trials.

The Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.

Research is a vital part of improving diagnosis and treatment for cancer. The NIHR has invested £4.4 million to directly funded pancreatic cancer research between 2018/19 and 2023/24. These investments are pivotal to informing efforts to improve cancer prevention, treatment and outcomes. An example of a recent award is the research, Translational proteomics to understand and overcome drug resistance to targeted anticancer drugs in KRAS and PIK3CA driven cancers.

Additionally, NIHR infrastructure funding supports the country’s leading experts to develop and deliver high-quality translational, clinical and applied research that is funded by the NIHR’s research programmes, other public funders of research, charities and the life sciences industry. In doing so, our investment plays a crucial role in underpinning the research funded by our partners.

The NIHR continues to encourage and welcome applications for research into any aspect of human health, including pancreatic cancer. Applications are subject to peer review and judged in open competition, with awards made based on the importance of the topic to patients and health and care services, value for money and scientific quality.

The Department works closely with the National Health Service, industry, academia, research regulators and charities to make clinical research in the United Kingdom more efficient, more competitive, and more accessible, with the aim of ensuring that all patients, including those with pancreatic cancer, have access to cutting-edge clinical research and innovative, lifesaving treatments.

Patients diagnosed with pancreatic cancer can access relevant research and clinical trials through the NIHR online service called 'Be Part of Research', which promotes participation in health and social care research, including research into pancreatic cancer, by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.